supports

AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ

Netherlands based-Acerta is developing cancer drugs that use the body's own defenses against the disease. On Monday, Acerta reported that 95 percent of patients with chronic lymphocytic leukemia positively responded to

Read the rest here:
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ

supports

U.S. consumers loosen purse strings as holidays start

U.S. consumers showed some muscle in November at the start of the holiday shopping season, suggesting enough momentum in the economy for the Federal Reserve to raise interest rates next week for the first time in nearly a decade. The outlook for consumer spending, which accounts for more than two-thirds of economic activity, got a lift from other data …

View post: 
U.S. consumers loosen purse strings as holidays start